Hepatitis C

Top Story

Inclusive criteria, generic drugs effective for HCV in limited resource nations

December 11, 2017

Researchers from the University of Cairo analyzed the rates of sustained virologic response among patients with hepatitis C in Egypt since the introduction of direct-acting antivirals to share data on the planning and prioritization of treatment in a nation with limited resources and high prevalence of HCV.

Prioritization based on fibrosis stage was not effective and enrollment for DAA therapy increased once the program included all stages of fibrosis. Additionally, the availability of generic drugs reduced costs and helped increased enrollment in the program.

In the Journals

Liver cancer incidence after HCV therapy linked to risk factors, not treatment

December 8, 2017
Direct-acting antiviral treatment for hepatitis C did not correlate with an increased risk for hepatocellular carcinoma in a large cohort study of both treated and…
In the JournalsPerspective

HCV nucleic acid test offers ‘opportunity’ to increase liver transplant pool

December 7, 2017
Utilizing hepatitis C antibody-positive but nucleic acid test-negative liver donors for HCV-negative liver transplant recipients opens up liver transplant options…
In the Journals

Resistance analysis of Epclusa shows patients may retreat with sofosbuvir

December 6, 2017
Treatment with Epclusa for 12 weeks resulted in high sustained virologic response rates among patients with hepatitis C genotypes 1 through 6, irrespective of baseline…
More Headlines »